Home > Balance Sheet > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Balance Sheet

SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Balance Sheet History

[Consolidated]

Mar2024Mar2023
EQUITY AND LIABILITIES
Share Capital ₹32 Cr₹32 Cr
    Equity - Authorised ₹43 Cr₹43 Cr
    Equity - Issued ₹32 Cr₹32 Cr
    Equity Paid Up ₹32 Cr₹32 Cr
    Equity Shares Forfeited --
    Adjustments to Equity --
    Preference Capital Paid Up --
    Face Value ₹1.00₹1.00
Share Warrants & Outstandings --
Total Reserves ₹93 Cr₹480 Cr
    Securities Premium ₹2,038 Cr₹2,038 Cr
    Capital Reserves --
    Profit & Loss Account Balance ₹-1,979 Cr₹-1,592 Cr
    General Reserves ₹34 Cr₹34 Cr
    Other Reserves ₹0.01 Cr-
Reserve excluding Revaluation Reserve ₹93 Cr₹480 Cr
Revaluation reserve --
Shareholder's Funds ₹126 Cr₹513 Cr
Minority Interest --
Long-Term Borrowings --
Secured Loans --
    Non Convertible Debentures --
    Converible Debentures & Bonds --
    Packing Credit - Bank --
    Inter Corporate & Security Deposit --
    Term Loans - Banks --
    Term Loans - Institutions --
    Other Secured --
Unsecured Loans --
    Fixed Deposits - Public --
    Loans and advances from subsidiaries --
    Inter Corporate Deposits (Unsecured) --
    Foreign Currency Convertible Notes --
    Long Term Loan in Foreign Currency --
    Loans - Banks --
    Loans - Govt. --
    Loans - Others --
    Other Unsecured Loan --
Deferred Tax Assets / Liabilities ₹-1.26 Cr-
    Deferred Tax Assets ₹30 Cr₹28 Cr
    Deferred Tax Liability ₹28 Cr₹28 Cr
Other Long Term Liabilities ₹118 Cr₹130 Cr
Long Term Trade Payables --
Long Term Provisions ₹6.05 Cr₹8.14 Cr
Total Non-Current Liabilities ₹123 Cr₹138 Cr
Current Liabilities --
Trade Payables ₹142 Cr₹148 Cr
    Sundry Creditors ₹142 Cr₹148 Cr
    Acceptances --
    Due to Subsidiaries- Trade Payables --
Other Current Liabilities ₹62 Cr₹24 Cr
    Bank Overdraft / Short term credit --
    Advances received from customers -₹0.00 Cr
    Interest Accrued But Not Due ₹0.07 Cr-
    Share Application Money -₹0.00 Cr
    Current maturity of Debentures & Bonds --
    Current maturity - Others --
    Other Liabilities ₹62 Cr₹24 Cr
Short Term Borrowings ₹47 Cr₹0.05 Cr
    Secured ST Loans repayable on Demands ₹47 Cr₹0.05 Cr
    Working Capital Loans- Sec ₹47 Cr₹0.05 Cr
    Buyers Credits - Unsec --
    Commercial Borrowings- Unsec --
    Other Unsecured Loans ₹-47 Cr₹-0.05 Cr
Short Term Provisions ₹14 Cr₹6.49 Cr
    Proposed Equity Dividend --
    Provision for Corporate Dividend Tax --
    Provision for Tax ₹1.65 Cr-
    Provision for post retirement benefits --
    Preference Dividend --
    Other Provisions ₹12 Cr₹6.49 Cr
Total Current Liabilities ₹265 Cr₹179 Cr
Total Liabilities ₹514 Cr₹830 Cr
ASSETS
Gross Block ₹157 Cr₹146 Cr
Less: Accumulated Depreciation ₹50 Cr₹40 Cr
Less: Impairment of Assets --
Net Block ₹108 Cr₹106 Cr
Lease Adjustment A/c --
Capital Work in Progress ₹1.27 Cr₹1.87 Cr
Non Current Investments --
Long Term Investment --
    Quoted --
    Unquoted --
Long Term Loans & Advances ₹68 Cr₹65 Cr
Other Non Current Assets ₹25 Cr₹178 Cr
Total Non-Current Assets ₹244 Cr₹375 Cr
Current Assets Loans & Advances --
Currents Investments ₹1.80 Cr₹291 Cr
    Quoted ₹1.80 Cr₹96 Cr
    Unquoted -₹195 Cr
Inventories --
    Raw Materials --
    Work-in Progress --
    Finished Goods --
    Packing Materials --
    Stores  and Spare --
    Other Inventory --
Sundry Debtors ₹16 Cr₹33 Cr
    Debtors more than Six months ₹6.55 Cr-
    Debtors Others ₹11 Cr₹33 Cr
Cash and Bank ₹155 Cr₹112 Cr
    Cash in hand ₹0.00 Cr₹0.00 Cr
    Balances at Bank ₹155 Cr₹112 Cr
    Other cash and bank balances --
Other Current Assets ₹42 Cr₹3.98 Cr
    Interest accrued on Investments ₹14 Cr₹0.63 Cr
    Interest accrued on Debentures --
    Deposits with Government --
    Interest accrued and or due on loans --
    Prepaid Expenses ₹4.82 Cr₹3.33 Cr
    Other current_assets ₹23 Cr₹0.02 Cr
Short Term Loans and Advances ₹54 Cr₹16 Cr
    Advances recoverable in cash or in kind ₹4.35 Cr₹4.58 Cr
    Advance income tax and TDS --
    Amounts due from directors --
    Due From Subsidiaries --
    Inter corporate deposits --
    Corporate Deposits --
    Other Loans & Advances ₹50 Cr₹11 Cr
Total Current Assets ₹269 Cr₹455 Cr
Net Current Assets (Including Current Investments) ₹4.33 Cr₹276 Cr
Miscellaneous Expenses not written off --
Total Assets ₹514 Cr₹830 Cr
Contingent Liabilities ₹84 Cr₹84 Cr
Total Debt ₹47 Cr₹0.05 Cr
Book Value 3.8815.80
Adjusted Book Value 3.8815.80

Compare Balance Sheet of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹4,865.9 Cr -1.4% 33.9% -61.4% Stock Analytics
SYNGENE INTERNATIONAL ₹30,053.4 Cr 3.5% 14.8% 2.5% Stock Analytics
SAGILITY INDIA ₹19,699.0 Cr -1.1% 0.3% NA Stock Analytics
LATENT VIEW ANALYTICS ₹7,747.8 Cr 3% 3.7% -28.5% Stock Analytics
JUST DIAL ₹7,097.6 Cr -1.2% 5.4% -2.3% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,771.6 Cr 3% 4.3% NA Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-1.4%

33.9%

-61.4%

SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses